Translational Development Acquisition (TDACU) Other Operating Expenses (2023)

Translational Development Acquisition (TDACU) reported Other Operating Expenses of $485550.0 for Q4 2023.

Translational Development Acquisition (TDACU) Other Operating Expenses (2023) Analysis & Trends

Translational Development Acquisition has reported Other Operating Expenses for 1 years, with the latest figure at $485550.0 in Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $485550.0; the trailing twelve-month figure through Dec 2024 stood at $485550.0 (changed N/A YoY), and the FY2023 full-year result was $485550.0, changed N/A from the prior year.
  • Other Operating Expenses for Q4 2023 stood at $485550.0.
  • The five-year high for Other Operating Expenses was $485550.0 in Q4 2023, with the low at $485550.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Berto Acquisition 312.46 Mn 312.46 Mn -
3 Centurion Acquisition 311.65 Mn 311.65 Mn -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn -
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn -
6 WEN Acquisition 309.15 Mn 309.15 Mn -
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn -
8 Soulpower Acquisition 264.91 Mn 264.91 Mn -
9 BTC Development 262.16 Mn 262.16 Mn -
10 Translational Development Acquisition - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 485,550.00